(1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one

C47H76O18 — CID 177465613

IUPAC(1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one
SMILESCCC1OC(=O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@](C)(O)[C@H](CC(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](O)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C(C)C(O[C@H]3C[C@@H](O)[C@@H](OC)[C@@H](C)O3)C1C)O2
InChIInChI=1S/C47H76O18/c1-8-35-27(3)43(64-39-23-34(51)44(59-7)29(5)60-39)26(2)17-15-13-11-9-10-12-14-16-18-31(62-45-42(56)41(55)40(54)28(4)61-45)22-37-46(6,57)36(52)25-47(58,65-37)24-30(48)21-33(50)32(49)19-20-38(53)63-35/h9-18,26-37,39-45,48-52,54-58H,8,19-25H2,1-7H3/b10-9+,13-11+,14-12+,17-15+,18-16+/t26?,27?,28-,29-,30+,31?,32-,33-,34-,35?,36+,37+,39+,40-,41+,42+,43?,44+,45+,46+,47-/m1/s1
InChIKeyOCINEXWUTLUUBF-PIDMQJPCSA-N
MW929.11 g/mol
LogP1.11
Rot. Bonds6

About (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one

(1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one (PubChem CID 177465613) has the molecular formula C47H76O18 and a molecular weight of 929.11 g/mol. Its IUPAC name is (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one.

Molecular Properties

Compound Name(1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one
PubChem CID177465613
Molecular FormulaC47H76O18
Molecular Weight929.11 g/mol
Exact Mass928.50
IUPAC Name(1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one
SMILESCCC1OC(=O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@](C)(O)[C@H](CC(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](O)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C(C)C(O[C@H]3C[C@@H](O)[C@@H](OC)[C@@H](C)O3)C1C)O2
InChIInChI=1S/C47H76O18/c1-8-35-27(3)43(64-39-23-34(51)44(59-7)29(5)60-39)26(2)17-15-13-11-9-10-12-14-16-18-31(62-45-42(56)41(55)40(54)28(4)61-45)22-37-46(6,57)36(52)25-47(58,65-37)24-30(48)21-33(50)32(49)19-20-38(53)63-35/h9-18,26-37,39-45,48-52,54-58H,8,19-25H2,1-7H3/b10-9+,13-11+,14-12+,17-15+,18-16+/t26?,27?,28-,29-,30+,31?,32-,33-,34-,35?,36+,37+,39+,40-,41+,42+,43?,44+,45+,46+,47-/m1/s1
InChIKeyOCINEXWUTLUUBF-PIDMQJPCSA-N
XLogP1.11
TPSA283.98 Ų
H-Bond Donors10
H-Bond Acceptors18
Rotatable Bonds6
Heavy Atoms65
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500929.11
LogP ≤ 51.11
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1018

Analyze (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one?
The IUPAC name of (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one (CID 177465613) is (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one.
What is the SMILES notation for (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one?
The canonical SMILES for (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one is CCC1OC(=O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@](C)(O)[C@H](CC(O[C@@H]3O[C@H](C)[C@@H](O)[C@H](O)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C(C)C(O[C@H]3C[C@@H](O)[C@@H](OC)[C@@H](C)O3)C1C)O2.
What is the InChIKey of (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one?
The InChIKey is OCINEXWUTLUUBF-PIDMQJPCSA-N. The full InChI is InChI=1S/C47H76O18/c1-8-35-27(3)43(64-39-23-34(51)44(59-7)29(5)60-39)26(2)17-15-13-11-9-10-12-14-16-18-31(62-45-42(56)41(55)40(54)28(4)61-45)22-37-46(6,57)36(52)25-47(58,65-37)24-30(48)21-33(50)32(49)19-20-38(53)63-35/h9-18,26-37,39-45,48-52,54-58H,8,19-25H2,1-7H3/b10-9+,13-11+,14-12+,17-15+,18-16+/t26?,27?,28-,29-,30+,31?,32-,33-,34-,35?,36+,37+,39+,40-,41+,42+,43?,44+,45+,46+,47-/m1/s1.
What are the key properties of (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one?
(1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one has a molecular weight of 929.11 g/mol, XLogP of 1.11, 6 rotatable bonds, 10 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,3S,5R,6R,15E,17E,19E,21E,23E,27S,28S,29S)-11-ethyl-1,3,5,6,28,29-hexahydroxy-13-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-12,14,28-trimethyl-25-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-10,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaen-9-one is sourced from PubChem (CID 177465613), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).